Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Crexendo | CXDO | Nov 19, 2024 | 5.12 | +2.40 |
CRH | CRH | Nov 19, 2024 | 99.79 | +0.14 |
Cricut A | CRCT | Nov 19, 2024 | 5.24 | +0.96 |
Crinetics Pharmaceuticals | CRNX | Nov 19, 2024 | 55.17 | +2.74 |
CRISPR Therapeutics | CRSP | Nov 19, 2024 | 46.97 | -0.70 |
Criteo ADR | CRTO | Nov 19, 2024 | 38.24 | +4.67 |
Critical Metals | CRML | Nov 19, 2024 | 6.04 | +2.20 |
Crocs | CROX | Nov 19, 2024 | 97.98 | +1.52 |
Cronos Group | CRON | Nov 19, 2024 | 2.03 | -0.49 |
Cross Country Healthcare | CCRN | Nov 19, 2024 | 10.37 | +0.29 |
Cross Timbers Royalty Royalty Trust | CRT | Nov 19, 2024 | 10.04 | -1.08 |
CrossAmerica Partners LP Unit | CAPL | Nov 19, 2024 | 20.04 | +0.20 |
CrossFirst Bankshares | CFB | Nov 19, 2024 | 17.08 | -0.06 |
CrowdStrike A | CRWD | Nov 19, 2024 | 353.29 | +3.01 |
Crown Castle | CCI | Nov 19, 2024 | 104.47 | -0.11 |
Crown Crafts | CRWS | Nov 19, 2024 | 4.50 | +1.58 |
Crown ElectroKinetics | CRKN | Nov 19, 2024 | 0.83 | -2.35 |
Crown Holdings | CCK | Nov 19, 2024 | 89.54 | +0.18 |
Crown LNG | CGBS | Nov 19, 2024 | 0.35 | -6.95 |
Cryo-Cell International | CCEL | Nov 19, 2024 | 8.04 | -2.19 |
CryoPort | CYRX | Nov 19, 2024 | 6.93 | +3.51 |
CS Disco | LAW | Nov 19, 2024 | 5.44 | -0.55 |
CSG Systems International | CSGS | Nov 19, 2024 | 54.22 | +0.56 |
CSP | CSPI | Nov 19, 2024 | 13.03 | +2.28 |
CSW Industrials | CSWI | Nov 19, 2024 | 416.48 | +1.64 |
CSX | CSX | Nov 19, 2024 | 34.60 | -1.06 |
CTO Realty Growth | CTO | Nov 19, 2024 | 19.64 | +0.72 |
CTO Realty Growth A Pref | CTO-A | Nov 19, 2024 | 23.97 | +0.29 |
CTS | CTS | Nov 19, 2024 | 52.37 | -2.42 |
CubeSmart | CUBE | Nov 19, 2024 | 48.98 | +0.74 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.